Millennium Management’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-30,000
Closed -$1.27M 6464
2024
Q3
$1.27M Sell
30,000
-40,000
-57% -$1.7M ﹤0.01% 4079
2024
Q2
$2.82M Buy
70,000
+40,000
+133% +$1.67M ﹤0.01% 3223
2024
Q1
$1.06M Buy
30,000
+20,000
+200% +$536K ﹤0.01% 4240
2023
Q4
$296K Buy
+10,000
New +$207K ﹤0.01% 4963
2023
Q3
Sell
-20,000
Closed -$491K 6567
2023
Q2
$491K Buy
+20,000
New +$643K ﹤0.01% 4564

Other funds holding TNDM

Millennium Management's TNDM Position: Q1 2026 in Review

Millennium Management increased its Tandem Diabetes Care (TNDM) stake by 31% in Q1 2026, buying an estimated $3.87M and bringing the position to 761,672 shares worth $14.6M. The position accounts for 0.01% of the portfolio, ranked #1813.

Millennium Management first reported a position in TNDM in Q4 2013 and has held it in 46 quarters since. The position peaked at $75.4M in Q2 2020. 272 funds tracked by Wall St. Rank hold TNDM as of Q1 2026.

  • Millennium Management held 761,672 shares of Tandem Diabetes Care worth $14.6M as of Q1 2026.
  • Millennium Management bought 178,099 Tandem Diabetes Care shares in Q1 2026, an estimated $3.87M.
  • Tandem Diabetes Care made up 0.01% of Millennium Management's portfolio in Q1 2026, its #1813 holding.
  • Millennium Management first reported a position in Tandem Diabetes Care in Q4 2013 and has held it in 46 quarters since.
  • Millennium Management's Tandem Diabetes Care position peaked at $75.4M in Q2 2020.
  • 272 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.